Market Announcement. NABOTA® Packaging Update.
Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda. (“M8”), responsible for the exclusive importation and commercialization of NABOTA® (botulinum toxin...
Notice Regarding Theft of Medication March 23, 2025
Dear customers and healthcare professionals, our top priority is to ensure the quality, efficacy, and safety of those who use...
Notice Regarding Theft of Medication May 18, 2025
Dear customers and healthcare professionals, our top priority is to ensure the quality, efficacy, and safety of those who use...
Notice of Temporary Suspension of Imports for the Medications Haldol (haloperidol) and Haldol Decanoate(haloperidol decanoate)
In accordance with Resolution RDC No. 18/2014, issued by Anvisa (the Brazilian Health Regulatory Agency), the company Moksha8 Brasil Indústria...
Report on Transparency and Pay Equity Between Women and Men
Notice of Registration Cancellation for the Drug Ultraproct LDO (fluocortolone pivalate, lidocaine hydrochloride)
In accordance with Resolution RDC No. 18/2014, issued by Anvisa (the Brazilian Health Regulatory Agency), Moksha8 Brasil Indústria e Comércio...
Cargo Theft Alert: NABOTA® 100U – Lot X25025
Notice of Lisodren’s Registration Cancellation
Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda (“M8 Pharmaceuticals”) announces that on May 7, 2024, it requested that the...
Leadership Announcements and New Arcera Structure
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...